Boston Scientific launched the AXIOS Stent and Electrocautery Enhanced Delivery System.
SonarMD entered into a partnership agreement with Rockford (Ill.) Gastroenterology Associates.
EndoChoice CEO Mark Gilreath bought 20,000 shares of the company’s stock.
Fujifilm Medical Systems U.S.A. added a new high-resolution Double Balloon Endoscope to its Double Balloon Endoscopy technology portfolio.
Findings from a late-stage clinical trial showed treatment with Janssen Biotech’s Stelara induced clinical response and remission in adult patients with moderate to severe Crohn’s disease refractory to TNF inhibitors.
EndoGastric Solutions presented three-year follow-up data from TEMPO, a prospective, randomized, multicenter clinical study, which showed that the Transoral Incisionless Fundoplication procedure with the EsophyX device was effective in controlling chronic gastroesophageal reflux disease.
More articles on GI/endoscopy:
6 GI physicians in the news — March 18, 2016
Drs. Paul Fishbein, Vicente Lago join Gastro Health — 3 highlights
GI physician leader to know: Dr. Paul Lebovitz of Allegheny Health Network
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.